Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

United Therapeutics gets rights to Lilly's tadalafil for PAH

Executive Summary

Eli Lilly has granted United Therapeutics (focuses on oncology, cardiovascular, and infectious diseases) exclusive rights to sell tadalafil (currently on the market as Cialis for erectile dysfunction) in the US and Puerto Rico for pulmonary arterial hypertension (PAH).
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Equity
    • R+D and Marketing-Licensing
    • Includes Royalty or Profit Split Information
    • Includes Contract
    • Reverse Licensing

Related Companies

UsernamePublicRestriction

Register